Organon To Present at the 43rd Annual J.P. Morgan Healthcare Conference

BusinesswireDec 19 20:30

Goldman Sachs Maintains Organon & Co(OGN.US) With Hold Rating, Maintains Target Price $20

Futu NewsDec 18 08:31 · Ratings

Organon Gets Expanded FDA Approval for VTAMA

Seeking AlphaDec 16 23:12

Organon Says Vtama Cream Approved by FDA for Atopic Dermatitis

MT NewswiresDec 16 21:24

FDA Approves VTAMA (Tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older

BusinesswireDec 16 20:30

Express News | FDA Approves Vtama® (Tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older

BreakingsDec 16 20:30